Negative Psychosis Prevention Trials-Reply

JAMA Psychiatry. 2017 Jun 1;74(6):652-653. doi: 10.1001/jamapsychiatry.2017.0184.

Authors

Patrick D McGorry¹, Barnaby Nelson¹, Paul Amminger²

Affiliations

¹ Orygen, National Centre of Excellence in Youth Mental Health, Parkville, Australia2Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.
² Orygen, National Centre of Excellence in Youth Mental Health, Parkville, Australia2Centre for Youth Mental Health, University of Melbourne, Parkville, Australia3Department of Psychiatry, Medical University of Vienna, Vienna, Austria.

PMID: 28403452
DOI: 10.1001/jamapsychiatry.2017.0184

No abstract available

Publication types

Comment

MeSH terms

Adolescent
Antipsychotic Agents*
Fatty Acids, Omega-3
Humans
Psychotic Disorders*

Substances

Antipsychotic Agents
Fatty Acids, Omega-3